HEALTH GUIDESINGREDIENTSRESEARCH
HomeIngredient LibraryBacillus coagulans
Gut Health✓ In DOG-1

Bacillus coagulans

Bacillus coagulans

A spore-forming probiotic with exceptional stability and gut-health supporting properties

What It Is

Bacillus coagulans is a spore-forming, lactic acid-producing bacterium used as a probiotic in human and animal supplements. Its ability to form heat-resistant spores makes it significantly more stable than most probiotic strains, allowing it to survive manufacturing, storage, and the acidic environment of the stomach to reach the intestine in active form.

Why It's Used

Bacillus coagulans is used in DOG-1 because of its exceptional stability and the growing evidence supporting its role in digestive and immune health. Unlike many probiotic strains that lose viability during storage or in stomach acid, Bacillus coagulans' spore-forming nature ensures that a high proportion of the administered dose reaches the intestine alive.

Biological Mechanism

Bacillus coagulans germinates from its spore form in the small intestine, where it produces lactic acid and antimicrobial compounds that support a healthy microbial environment. It competes with pathogens for adhesion sites, reinforces intestinal barrier integrity, and interacts with gut-associated immune cells to modulate immune responses.

Relevant Health Areas
  • Digestive Health
  • Gut Microbiome Balance
  • Immune Function
  • Intestinal Barrier Integrity

What Makes Bacillus coagulans Different?

Most probiotic bacteria are vegetative cells — they exist in an active, metabolizing state and are vulnerable to heat, moisture, and acidic conditions. Bacillus coagulans is different because it can form spores — dormant, highly protected structures that are resistant to heat, acid, and other environmental stresses. This spore-forming ability has two important practical implications.

First, Bacillus coagulans supplements remain stable at room temperature without refrigeration, maintaining viability throughout their shelf life. Second, when consumed, the spores survive the acidic environment of the stomach (pH 1-3) that kills many other probiotic strains, germinating in the more neutral environment of the small intestine where they can exert their effects.

Research on Bacillus coagulans

Bacillus coagulans has been studied in humans for digestive health, immune function, and inflammatory conditions. Human studies have found benefits for irritable bowel syndrome, acute diarrhea, and immune markers. While direct canine studies on Bacillus coagulans are more limited, the mechanisms by which it supports gut health are relevant across species.

A study by Marteau and colleagues found that Bacillus coagulans survived transit through the human gastrointestinal tract in significantly higher proportions than non-spore-forming Lactobacillus strains, supporting its use as a stable, effective probiotic. Research on its immune-modulating properties has found effects on natural killer cell activity and cytokine production in human studies.

Safety Profile

Bacillus coagulans has a well-established safety profile. It has GRAS (Generally Recognized As Safe) status in the United States for use in food and supplements. It is not associated with antibiotic resistance transfer concerns that affect some other probiotic strains (such as Enterococcus faecium). It is generally well-tolerated in dogs and other animals.

Where This Ingredient Appears in DOG-1

Bacillus coagulans is the probiotic strain used in DOG-1, providing 10 billion CFU per daily serving. It was selected for its spore-forming stability, which ensures consistent delivery of viable organisms to the intestine regardless of storage conditions.

Scientific References

  1. Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J. 2016;15(1):21. PMID: 26920054
  2. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73(2 Suppl):430S-436S. PMID: 11157352
  3. Pilla R, Suchodolski JS. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease. Front Vet Sci. 2020;6:498. PMID: 32010704